Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neuroendocrine Tumors × Drug Therapy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Breast Neoplasms 21 Colorectal Neoplasms 10 Neoplasms 9 Stomach Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Lung Neoplasms 7 Neoplasm Metastasis 5 Colonic Neoplasms 5 Esophageal Squamous Cell Carcinoma 4 Esophageal Neoplasms 4 Triple Negative Breast Neoplasms 3 Small Cell Lung Carcinoma 3 Pancreatic Neoplasms 3 Lymphoma, Follicular 3 Leukemia, Myeloid, Acute 3 Urinary Bladder Neoplasms 2 Sarcoma 2 Osteosarcoma 2 Neoplasms, Second Primary 2 Multiple Myeloma 2 Melanoma 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Head and Neck Neoplasms 2 Fatigue 2 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Thyroid Diseases 1

Interventions

lutetium Lu 177 dotatate 5 Data Collection 3 telotristat ethyl 2 Somatostatin 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Biopsy 2 lanreotide 1 copper dotatate CU-64 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sorafenib 1 Salvage Therapy 1 Radionuclide Imaging 1 Radiomics 1 Radiofrequency Ablation 1 Positron-Emission Tomography 1 Plastic Surgery Procedures 1 Phlebotomy 1 Octreotide 1 Lutetium-177 1 Lutetium 1 Liver Transplantation 1 Laparoscopy 1 Drug Therapy 1 Diet, Mediterranean 1 Cytidine Triphosphate 1 Cholecystectomy 1 Blood Specimen Collection 1 Biopsy, Large-Core Needle 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04464122 2025-04-03

REBORN

University of Roma La Sapienza

Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡